PROTEOMEDIX
ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer and the personalized treatment thereof.The first product currently developed is a blood-based test that enables the diagnosis of prostate cancer with significantly higher accuracy than today's clinical standard.This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.
PROTEOMEDIX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2010-03-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.proteomedix.com
Total Employee:
1+
Status:
Active
Contact:
41 44 733 40 90
Email Addresses:
[email protected]
Total Funding:
21.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx Google Maps
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Fagron SA
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
InSphero
InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Horizon Health
New Horizon Health investment in Debt Financing - ProteoMediX
Walter Fischl
Walter Fischl investment in Venture Round - ProteoMediX
several private
several private investment in Venture Round - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Venture Round - ProteoMediX
Altos Venture
Altos Venture investment in Venture Round - ProteoMediX
Altos Ventures
Altos Ventures investment in Series C - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series C - ProteoMediX
Altos Venture
Altos Venture investment in Series B - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series B - ProteoMediX
Zürcher Kantonal Bank
Zürcher Kantonal Bank investment in Series A - ProteoMediX
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-10 | Proteomedix appoints new CEO to launch their diagnostic test |
Official Site Inspections
http://www.proteomedix.com
- Host name: 159.100.255.20
- IP address: 159.100.255.20
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
